Cost-Effectiveness of Canakinumab From a Canadian Perspective for Recurrent Cardiovascular Events

Kevin E. Boczar(University of Ottawa), Doug Coyle(University of Ottawa), George A. Wells(University of Ottawa), Rob Beanlands(University of Ottawa)
CJC Open
January 17, 2022
Cited by 5


Related Papers